Does RIBOCICLIB Cause Soft tissue infection? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Soft tissue infection have been filed in association with RIBOCICLIB (KISQALI). This represents 0.0% of all adverse event reports for RIBOCICLIB.
7
Reports of Soft tissue infection with RIBOCICLIB
0.0%
of all RIBOCICLIB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Soft tissue infection From RIBOCICLIB?
Of the 7 reports, 5 (71.4%) required hospitalization.
Is Soft tissue infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Soft tissue infection?
METHOTREXATE (129)
PREDNISONE (105)
CYCLOPHOSPHAMIDE (98)
RITUXIMAB (98)
MYCOPHENOLATE MOFETIL (81)
VINCRISTINE (76)
DEXAMETHASONE (70)
TACROLIMUS (68)
DOXORUBICIN (64)
CYCLOSPORINE (53)
Which RIBOCICLIB Alternatives Have Lower Soft tissue infection Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN